Overview A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391(2) Status: Completed Trial end date: 2024-01-22 Target enrollment: Participant gender: Summary A clinical trial to compare and evaluate the safety and pharmacokinetics of CKD-391(2) Phase: Phase 1 Details Lead Sponsor: Chong Kun Dang Pharmaceutical